432 related articles for article (PubMed ID: 22325789)
1. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
[TBL] [Abstract][Full Text] [Related]
2. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
Ergin AB; Saralaya S; Olansky L
Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
[TBL] [Abstract][Full Text] [Related]
3. Incidental thyroid carcinoma in patients with Graves' disease.
Phitayakorn R; McHenry CR
Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
5. Incidental versus non-incidental thyroid carcinoma: Clinical presentation, surgical management and prognosis.
González-Sánchez-Migallón E; Flores-Pastor B; Pérez-Guarinos CV; Miguel-Perelló J; Chaves-Benito A; Illán-Gómez F; Carrillo-Alcaraz A; Aguayo-Albasini JL
Endocrinol Nutr; 2016 Nov; 63(9):475-481. PubMed ID: 27426718
[TBL] [Abstract][Full Text] [Related]
6. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
[TBL] [Abstract][Full Text] [Related]
7. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis.
Gul K; Di Ri Koc A; Ki Yak G; Ersoy PE; Ugras NS; Ozdemi D; Ersoy R; Cakir B
Minerva Endocrinol; 2009 Dec; 34(4):281-8. PubMed ID: 20046157
[TBL] [Abstract][Full Text] [Related]
8. ["Incidental" thyroid carcinoma among patients in surgical treatment for nontumors thyroid desease].
Nechaĭ OP; Larin OS; Cheren'ko SM; Sheptukha SA; Smoliar VA; Zolotar'ov PO
Klin Khir; 2012 Jul; (7):9-11. PubMed ID: 23033769
[TBL] [Abstract][Full Text] [Related]
9. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases.
Bradly DP; Reddy V; Prinz RA; Gattuso P
Surgery; 2009 Dec; 146(6):1099-104. PubMed ID: 19958937
[TBL] [Abstract][Full Text] [Related]
10. [Incidental carcinoma in thyroid pathology: our experience and review of the literature].
Pezzolla A; Lattarulo S; Milella M; Barile G; Pascazio B; Ciampolillo A; Fabiano G; Palasciano N
Ann Ital Chir; 2010; 81(3):165-9. PubMed ID: 21105480
[TBL] [Abstract][Full Text] [Related]
11. Toxic nodular goiter with thyroid papillary microcarcinoma.
Wang CY; Chang TC
ANZ J Surg; 2010 Jan; 80(1-2):117. PubMed ID: 20575904
[No Abstract] [Full Text] [Related]
12. [Hyperthyroidism and carcinoma of the thyroid gland].
Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
[TBL] [Abstract][Full Text] [Related]
13. [Thyroid diseases in sub-Saharan Africa].
Sidibé el H
Sante; 2007; 17(1):33-9. PubMed ID: 17897900
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
[TBL] [Abstract][Full Text] [Related]
15. [The clinical and laboratory findings in Graves' multinodular type disease].
Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental.
Alevizaki M; Papageorgiou G; Rentziou G; Saltiki K; Marafelia P; Loukari E; Koutras DA; Dimopoulos MA
Thyroid; 2009 Jul; 19(7):749-54. PubMed ID: 19534620
[TBL] [Abstract][Full Text] [Related]
17. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
[TBL] [Abstract][Full Text] [Related]
18. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
[TBL] [Abstract][Full Text] [Related]
19. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
20. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
